CML (Chronic Myeloid Leukemia) Explained: Stages, PBS Findings, Symptoms, and Prognosis

Chronic Myeloid Leukemia (CML) is a myeloproliferative neoplasm in which immature myeloid cells proliferate abnormally in the bone marrow.
One of its most defining features is the Philadelphia chromosome (t(9;22)(q34;q11)), found in the majority of patients. This genetic abnormality plays a pivotal role in diagnosis, monitoring, and targeted treatment.

---

1️⃣ Disease Phases of CML

Clinically, CML is divided into three phases. Each phase shows distinct peripheral blood smear (PBS) findings and clinical behaviors.

1. Chronic Phase

• Often asymptomatic
• Progressive leukocytosis
• PBS findings:
  • Marked neutrophilia
  • Left shift (myelocytes, metamyelocytes)
  • Basophilia
  • Platelet count normal or elevated

2. Accelerated Phase

• Symptoms become noticeable
• Increasing difficulty controlling WBC counts
• PBS findings:
  • Blasts 10–19%
  • Significant basophilia
  • Thrombocytosis or thrombocytopenia
  • Progressive anemia

3. Blast Crisis

• Transforms into an acute leukemia–like state
• Severe symptoms
• PBS findings:
  • Blasts ≥20%
  • Anemia, thrombocytopenia
  • Extramedullary blast proliferation

Left shift refers to the presence of less mature granulocyte precursors (myelocytes, metamyelocytes) in the peripheral blood—one of the hallmark features of CML.

---

2️⃣ PBS (Peripheral Blood Smear) Findings in Detail

Chronic Phase PBS

• WBC commonly 50,000–200,000/µL
• Increased neutrophils (segmented + band forms)
• Basophilia (often >10%)
• Platelets normal to high
• RBC typically normal early, mild anemia later

Accelerated Phase PBS

• Blasts 10–19%
• Marked basophilia
• Platelets fluctuating (↑ or ↓)
• Worsening anemia

Blast Crisis PBS

• Blasts ≥20%
• Smear resembles acute leukemia
• Severe anemia and thrombocytopenia

Basophilia is especially helpful in distinguishing CML from other myeloproliferative neoplasms.

---

3️⃣ Clinical Symptoms

Chronic Phase

• Mostly asymptomatic
• Often discovered incidentally via CBC test

Accelerated & Blast Phases

• Fatigue
• Weight loss
• Fever, night sweats
• Splenomegaly
• Bone pain
• Anemia- or infection-related symptoms

---

4️⃣ Prognosis

Before TKI Era

• Median survival: 3–5 years

After Introduction of TKIs (e.g., Imatinib)

• Dramatic improvement
• Many chronic-phase patients now achieve 10+ years of survival
• Deep molecular responses possible

Poor Prognostic Factors

• Older age
• Very high WBC count
• Rapid disease progression
• Entry into accelerated/blast phase

---

5️⃣ Quick Summary

• CML is a Philadelphia chromosome–driven myeloproliferative neoplasm.
• Key PBS features:
  • Left shift, basophilia, and variable blast percentages depending on stage.
• Symptoms range from asymptomatic to severe (especially in blast crisis).
• TKIs have dramatically improved survival—early diagnosis is crucial.

---

References

Kantarjian HM, et al. Chronic myeloid leukemia: current concepts and future directions. J Clin Oncol. 2019.
Hoffbrand AV, et al. Essential Haematology. 8th ed. Wiley-Blackwell, 2021.
Goldman JM, Melo JV. Advances in biology and new approaches to treatment. N Engl J Med. 2003.
Baccarani M, et al. European LeukemiaNet recommendations. Leukemia. 2020.
Bain BJ. Blood Cells: A Practical Guide. 5th ed. Wiley-Blackwell, 2015.